Table 3

Length of Stay (LOS) in Days before Starting Clozapine, on Clozapine Trial and after Clozapine Trial Discontinued

Hospital DaysDischarged on ClozapineClozapine Discontinued Prior to Discharge
Restored (n = 69)Not Restored (n = 104)Restored (n = 7)Not Restored (n = 11)Test Statp
Before starting clozapine227.19 ± 171.60330.03 ± 197.22353.86 ± 260.14413.64 ± 215.52F = 5.632 (df = 3).001a
On clozapine174.43 ± 142.29239.66 ± 113.7799.86 ± 83.01149.27 ± 122.37F = 6.464 (df = 3).000b
After clozapine discontinued93.43 ± 69.74195.55 ± 164.88F = 2.371 (df = 1).143c
Total Hospital (Length of Stay)397.25 ± 230.87567.04 ± 209.75545.43 ± 250.16673.36 ± 163.77F = 10.75 (df = 3).000d
  • Note. Statistical significance was determined by using analysis of variance and the post hoc Tukey’s multiple comparisons test. Cloz/Rest = patients maintained on clozapine until discharge and restored to competency; ClozDC/NonRest = patients discontinued from clozapine and not restored to competency; Cloz/NonRest = patients maintained on clozapine and not restored to competency.

  • a There were statistically significant between-group differences in length of stay (LOS) before the start of the clozapine trial, F(3, 187) = 5.632, p = .001): Cloz/Rest (227.19 ± 171.60 days) was shorter than ClozDC/NonRest (413.64 ± 215.52 days) and Cloz/NonRest (330.03 ± 197.22 days).

  • b Among those who were discharged on clozapine there were statistically significant differences in the time on clozapine, F(3, 187) = 6.464, p = .000): Cloz/NonRest (239.66 ± 113.77 days) and Cloz/Rest (174.43 ± 142.29 days).

  • c Among those who had clozapine discontinued before hospital discharge, there were no statistically significant differences between groups in the length of stay (LOS) after clozapine was discontinued.

  • d There were statistically significant between group differences in total LOS (F [3, 187] = 10.75, p = .000): Cloz/Rest (397.25 ± 230.87 days) was shorter than ClozDC/NonRest (673.36 ± 163.77 days) and Cloz/NonRest (567.04 ± 209.75 days).